Crossref
The use of midostaurin in the treatment of advanced systemic mastocytosis
Hematology in Clinical Practice · 2021
DOI: 10.5603/hcp.2021.0010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology in Clinical Practice, 2021. Verfasst von Marek Hus und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hus, M., Szudy-Szczyrek, A., Kozińska, J., & Bachanek-Mitura, O. (2021). The use of midostaurin in the treatment of advanced systemic mastocytosis. Hematology in Clinical Practice. https://doi.org/10.5603/hcp.2021.0010
Vancouver
Hus M, Szudy-Szczyrek A, Kozińska J, Bachanek-Mitura O. The use of midostaurin in the treatment of advanced systemic mastocytosis. Hematology in Clinical Practice. 2021. doi:10.5603/hcp.2021.0010
BibTeX
@article{Hus2021,
author = {Hus, Marek and Szudy-Szczyrek, Aneta and Kozińska, Justyna and Bachanek-Mitura, Oliwia},
title = {The use of midostaurin in the treatment of advanced systemic mastocytosis},
journal = {Hematology in Clinical Practice},
year = {2021},
doi = {10.5603/hcp.2021.0010}
}
EUVIMED